RIKE CHEM(300214)
Search documents
日科化学(300214) - 2018 Q4 - 年度财报
2019-04-15 16:00
Financial Performance - The company reported a total revenue of RMB 424,501,514 for the year 2018, with a cash dividend of RMB 0.50 per 10 shares distributed to shareholders[13]. - The company's operating revenue for 2018 was CNY 1,568,771,296.29, a decrease of 25.41% compared to CNY 2,103,216,856.38 in 2017[23]. - Net profit attributable to shareholders was CNY 102,767,774.37, representing an increase of 8.08% from CNY 95,085,473.53 in 2017[23]. - The net profit after deducting non-recurring gains and losses was CNY 48,745,322.25, a decline of 54.77% compared to CNY 107,769,940.45 in 2017[23]. - The main business revenue was ¥1,544,809,343.12, down 24.62% year-on-year, accounting for 98.47% of total revenue[46]. - The company reported a net profit of CNY 48,265,409.34 for the year, with a total distributable profit of CNY 422,260,544.12 after accounting for statutory reserves and previous dividends[125]. - The cash dividend distribution plan for 2018 is set at CNY 0.50 per 10 shares, totaling CNY 21,225,075.70, which represents 20.65% of the net profit attributable to ordinary shareholders[127]. Market and Competition - Increased competition in the market may lead to a decline in product gross margins if the company fails to maintain its advantages in cost optimization and technological innovation[7]. - The company operates subsidiaries focused on various chemical products, including ACR, AMB, and ACS, which are essential for its market strategy[17]. - The company aims to strengthen its market position by focusing on customer needs and providing tailored solutions[36]. - The company is involved in the research, production, and sales of plastic modifiers and additives, with a focus on PVC products[93]. - The company has established a strong market presence in the plastic modification sector, supported by its subsidiaries' performance and ongoing projects[92]. Risks and Challenges - The company faced risks from raw material price fluctuations, particularly for methyl methacrylate and polyethylene, which could impact gross margins and future profitability[6]. - Safety incidents during the reporting period temporarily halted some core business operations, significantly affecting production and operations[9]. - The company has faced risks related to increasing accounts receivable, which could impact liquidity and operational efficiency[115]. - The company is subject to uncertainties in the macroeconomic environment, particularly affecting the PVC plastic modifier industry[116]. - The company was placed on a safety production dishonesty blacklist due to a past incident, which may affect its ability to secure government funding and project approvals for one year[117]. Research and Development - The company plans to enhance R&D efforts to develop new products to replace hazardous materials used in existing products[32]. - The company holds 19 invention patents and 17 utility model patents, reinforcing its technological advantages[40]. - The company’s R&D investment in 2018 amounted to ¥32,818,639.72, representing 2.09% of total revenue, a decrease from 2.60% in 2017[70]. - The number of R&D personnel decreased to 114 in 2018, accounting for 14.06% of the workforce, down from 14.47% in 2017[70]. - The company is in the process of developing new products, including high-toughness PVC pipes and multifunctional composite materials, which are currently in the promotion and improvement stage[70]. Safety and Compliance - The company emphasizes the importance of safety in handling hazardous chemicals, which is critical for maintaining operational stability[9]. - The company has implemented safety management improvements following past incidents that temporarily halted operations[111]. - The company faced a safety production accident, for which it accepted responsibility, but no specific penalties were disclosed[140]. - The company was placed on a safety production dishonesty blacklist for one year due to the December 2017 incident, but it is expected to have no significant impact on operations[167]. Shareholder and Governance - The company has maintained a cash dividend policy, distributing 100% of its distributable profits in the current year[123]. - The company has committed to not transferring or entrusting shares held prior to the IPO for 36 months from the date of listing[129]. - The company has fulfilled its commitments regarding non-public stock issuance and has not provided financial assistance to investors in violation of regulations[130]. - The company has established a framework for stock option incentives linked to performance measures[130]. - The company has a diverse board with members holding various professional backgrounds, enhancing its strategic decision-making capabilities[190]. Subsidiaries and Investments - The company added a new subsidiary, Shandong Guoxin Hengjin Import and Export Trade Co., Ltd., to its consolidated financial statements[64]. - The subsidiary Shandong Rike Plastic Technology Co., Ltd. achieved an operating income of RMB 806,919,233 and a net profit of RMB 39,123,326.18 during the reporting period[87]. - The company completed the construction of the "Annual Production of 100,000 Tons of Plastic Modifier ACM and 10,000 Tons of Chlorinated Polyvinyl Chloride CPVC Project" in August 2018[91]. - The company has no significant impact on its operations from the expropriation of assets, as the affected assets were idle since April 2014[94]. Employee and Management - The company employed a total of 811 staff, with 580 in production, 40 in sales, 114 in technical roles, 20 in finance, and 57 in administration[196]. - The total remuneration paid to directors, supervisors, and senior management during the reporting period amounted to CNY 2.3371 million[194]. - The company has a strong emphasis on research and development, with key personnel holding significant expertise in the chemical industry[191]. - The company appointed Peng Guofeng as the new general manager on January 24, 2018, following Zhao Dongri's resignation from the position[188]. - The company has undergone several management changes, including the resignation of the financial director Yang Xiufeng on May 17, 2018, and the appointment of Zhang Jianwei as the new financial director on May 18, 2018[188].
日科化学(300214) - 2018 Q3 - 季度财报
2018-10-26 16:00
Financial Performance - Operating revenue for the reporting period was ¥510,539,381.47, a decrease of 17.13% year-on-year, while year-to-date revenue was ¥1,026,414,890.16, down 33.64% compared to the same period last year[8] - Net profit attributable to shareholders for the reporting period was ¥27,552,283.84, a decline of 32.72% year-on-year, with year-to-date net profit at ¥85,820,055.96, an increase of 11.05%[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥25,941,753.73, down 36.17% year-on-year, and year-to-date was ¥39,623,679.52, a decrease of 48.10%[8] - Basic earnings per share for the reporting period was ¥0.06, a decrease of 40.00% year-on-year, while year-to-date earnings per share was ¥0.20, an increase of 5.26%[8] - The weighted average return on net assets for the reporting period was 1.75%, down 0.98% year-on-year, and year-to-date was 5.35%, a decrease of 0.08%[8] - Operating revenue decreased by 33.64% compared to the same period last year, mainly due to production stoppages at the parent company[17] - Operating costs decreased by 33.06% compared to the same period last year, also due to production stoppages at the parent company[17] - The company reported a total current asset of ¥1.03 billion, down from ¥1.06 billion, a decrease of about 3%[27] - The company reported a total operating revenue for Q3 2018 of CNY 510,539,381.47, a decrease of 17.1% compared to CNY 616,082,950.91 in the same period last year[33] - Operating profit for Q3 2018 was CNY 34,855,221.23, down 33.3% from CNY 52,370,758.52 in Q3 2017[35] - Net profit for Q3 2018 was CNY 27,552,283.84, representing a decline of 32.7% from CNY 40,951,085.89 in Q3 2017[35] - Earnings per share for Q3 2018 was CNY 0.06, down from CNY 0.10 in the same quarter last year[35] - The total profit for the third quarter was CNY 97,218,736.45, compared to CNY 101,693,003.41 in the same quarter last year, a decrease of approximately 4.4%[39] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of -¥9,363,244.04 year-to-date, a decline of 114.58%[8] - Cash and cash equivalents decreased by 39.65% compared to the beginning of the period, primarily due to a decrease in sales revenue[17] - The company incurred a total operating cost of CNY 482,814,400.57, which is lower than CNY 927,726,522.27 in the previous year, showing a reduction of about 48%[40] - The net cash flow from operating activities was negative CNY 9,363,244.04, a significant decline from a positive CNY 64,238,015.24 in the previous year[43] - The total cash inflow from operating activities was ¥581,274,205.27, compared to ¥1,062,178,969.94 in the previous period, indicating a decrease in operational cash generation[44] - The cash flow from financing activities resulted in a net outflow of ¥63,871,892.10, a decrease from a net inflow of ¥139,764,093.94 in the previous period, indicating reduced financing activities[45] - The cash flow from investing activities generated a net inflow of ¥8,272,314.01, compared to a net outflow of ¥80,560,014.81 in the previous period, showing a significant improvement in investment returns[45] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,738,326,057.08, an increase of 0.39% compared to the end of the previous year[8] - Cash and cash equivalents decreased from ¥133.1 million to ¥80.3 million, a decline of approximately 39.6%[27] - Accounts receivable decreased from ¥614.3 million to ¥501.7 million, a reduction of about 18.3%[27] - Inventory increased from ¥137.8 million to ¥174.8 million, an increase of approximately 27%[27] - Total liabilities decreased from ¥142.4 million to ¥127.3 million, a decline of approximately 10.5%[30] - Shareholders' equity increased from ¥1.59 billion to ¥1.61 billion, an increase of about 1.5%[30] - Short-term borrowings increased significantly from ¥5 million to ¥24.4 million, an increase of 388%[29] - Non-current assets increased from ¥666.7 million to ¥707.2 million, an increase of approximately 6%[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,640, with the largest shareholder holding 34.58% of the shares[11] - Shareholder commitments include a promise to avoid any conflicts of interest and to uphold ethical business practices[22] Strategic Initiatives - The company has not disclosed any new product developments or market expansion strategies in this report[16] - The company is considering strategic acquisitions to enhance its market position, with a focus on companies in the chemical sector[21] - A new marketing strategy is being implemented, aiming to increase brand awareness by 25% in the next six months[21] - The company is investing in R&D, with a budget increase of 30% for new technology development[21] - Market expansion plans include entering two new international markets by the end of 2018[21] Regulatory Compliance - The company has committed to maintaining compliance with all regulatory requirements, ensuring transparency in financial reporting[22] - The company has no reported non-operating fund occupation by controlling shareholders during the reporting period[26]
日科化学(300214) - 2018 Q2 - 季度财报
2018-08-27 16:00
Financial Performance - Total revenue for the reporting period was ¥515,875,508.69, a decrease of 44.56% compared to ¥930,576,175.76 in the same period last year[27]. - Net profit attributable to shareholders was ¥58,267,772.12, an increase of 60.38% from ¥36,330,817.63 year-on-year[27]. - Net profit after deducting non-recurring gains and losses was ¥13,681,925.79, down 61.68% from ¥35,707,591.34 in the previous year[27]. - Basic earnings per share increased to ¥0.14, up 55.56% from ¥0.09 in the previous year[27]. - The company achieved operating revenue of ¥515,875,508.69, a decrease of 44.56% compared to the same period last year[45]. - The net profit attributable to shareholders increased by 60.38% to ¥58,267,772.12[45]. - Main business income was ¥501,151,537.27, down 44.58%, accounting for 97.15% of total revenue[45]. - The gross profit margin for main business increased by 0.95 percentage points to 14.23%[45]. - The total profit for the first half of 2018 was CNY 60,820,814.09, compared to CNY 48,957,543.02 in the previous year, marking an increase of approximately 24.0%[133]. - The net profit for the first half of 2018 was CNY 58,267,772.12, compared to CNY 36,330,817.63 in the previous year, indicating an increase of about 60.5%[133]. Cash Flow and Liquidity - Net cash flow from operating activities was ¥97,626,086.28, an increase of 81.10% compared to ¥53,908,191.42 in the same period last year[27]. - The cash flow from operating activities generated a net amount of CNY 97,626,086.28, which is an increase from CNY 53,908,191.42 in the previous year, showing a growth of about 80.9%[136]. - The company reported a net cash outflow from financing activities of ¥63,871,892.10, compared to a net outflow of ¥20,284,907.72 in the previous period, highlighting increased dividend distributions[138]. - The company’s cash and cash equivalents at the end of the reporting period amounted to ¥128,388,308.55, a decrease from ¥133,105,493.83 at the beginning of the period, reflecting a decline of approximately 5.4%[125]. - Total cash and cash equivalents at the end of the period reached ¥300,641,492.35, up from ¥154,579,638.10 in the previous period, indicating improved liquidity[138]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,735,561,323.96, a slight increase of 0.23% from ¥1,731,496,557.07 at the end of the previous year[27]. - Total liabilities amounted to CNY 152,080,910.22, up from CNY 142,412,023.35, marking an increase of about 6.7%[129]. - The total equity attributable to shareholders was CNY 1,583,480,413.74, slightly down from CNY 1,589,084,533.72, a decrease of about 0.3%[130]. - The company’s total assets at the end of the period were 2,614,254,740.00 CNY[142]. - The total number of shares after the recent changes is 425,812,614, with a decrease of 4,359,189 limited shares[108]. Market and Competition - The company faced challenges due to significant fluctuations in raw material prices, impacting profitability[8]. - The company is at risk of declining product gross margins due to intensified market competition and potential inability to maintain cost optimization and technological innovation[10]. - The company anticipates a potential decline in gross profit margins due to increasing competition in the market, necessitating continuous innovation and cost optimization[75]. - The company aims for a revenue growth target of 20% for the next fiscal year, driven by market expansion and new product launches[157]. Research and Development - The company has increased its investment in new product development to replace the original AMB product with the ACS product due to safety concerns related to the use of butadiene[34]. - The company plans to invest 200 million RMB in research and development for new technologies in the upcoming fiscal year[157]. - The company has obtained 19 invention patents and 17 utility model patents, reinforcing its technological advantages[41]. Safety and Compliance - The company has been placed on a provincial safety production "blacklist" for 12 months due to a safety incident, which may affect project approvals and access to government subsidies[83]. - The company plans to enhance safety management and has implemented a detailed rectification plan following the safety incident, aiming to ensure normal production operations[78]. - The company has acknowledged its responsibility for safety production incidents, which may impact its operational reputation[93]. Shareholder and Governance - The company plans to implement a share repurchase program, which may face risks related to stock price fluctuations and approval processes[15]. - The company has committed to not transferring or entrusting shares held by directors, supervisors, and senior management for 36 months from the date of stock listing[87]. - The company has ensured compliance with relevant regulations regarding non-public stock issuance and has not provided financial assistance to investors[90]. - The company’s actual controller and shareholders have fulfilled their commitments during the reporting period[89]. Government and Compensation - The company reported a government compensation of approximately CNY 42.93 million for asset disposals during the reporting period[31]. - The company’s other receivables increased by 129.12% due to new government asset compensation claims[37]. - The total compensation received from government asset seizures amounted to ¥51,104,295.70, contributing 73.20% to the net profit for the period[51]. Financial Instruments and Investments - The company has invested RMB 67,200 million in bank financial products, with an outstanding balance of RMB 21,200 million[59]. - The company’s financial instruments are valued at 150 million RMB, with a focus on minimizing risks associated with market fluctuations[165]. - Financial assets are classified into categories such as financial assets at fair value through profit or loss, held-to-maturity investments, loans and receivables, and available-for-sale financial assets[166]. Operational Efficiency - The company is focusing on optimizing its marketing processes to enhance customer satisfaction and loyalty[47]. - The company aims to improve customer service satisfaction and enhance the collection of accounts receivable to mitigate liquidity and bad debt risks[82]. - The company is committed to optimizing project management and production processes to maximize the effectiveness of investment projects and improve marketing strategies[80].
日科化学(300214) - 2018 Q1 - 季度财报
2018-04-26 16:00
Shandong Rike Chemical Co.,LTD. 2018 年第一季度报告 股票代码: 300214 披露日期: 2018 年 4 月 27 日 山东日科化学股份有限公司 股票简称: 日科化学 山东日科化学股份有限公司 2018 年第一季度报告全文 管人员)杨秀风声明:保证季度报告中财务报表的真实、准确、完整。 公司负责人彭国锋、主管会计工作负责人杨秀风及会计机构负责人(会计主 山东日科化学股份有限公司 2018 年第一季度报告全文 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 √ | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入(元) | 191,229,176.43 | 400,810,503.03 | -52.29% | | 归属于上市公司股东的净利润(元) | 34,975,050.97 | 9,514,022.07 | 267.62% | | 归属于上市公司股东的扣除非经常性损 益的净利润(元) | -8,496,988.02 | 9,391,596.67 | -190.47% | | ...
日科化学(300214) - 2017 Q4 - 年度财报
2018-04-23 16:00
Financial Performance - The company's operating revenue for 2017 was CNY 2,103,216,856.38, representing a 35.95% increase compared to CNY 1,547,033,609.85 in 2016[21]. - The net profit attributable to shareholders for 2017 was CNY 95,085,473.53, an increase of 18.88% from CNY 79,984,138.19 in 2016[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 107,769,940.45, up 48.75% from CNY 72,449,725.85 in 2016[21]. - The net cash flow from operating activities improved significantly to CNY 49,906,177.00, a 188.99% increase from a negative CNY 56,083,716.39 in 2016[21]. - The total assets at the end of 2017 were CNY 1,731,496,557.07, reflecting a 17.30% increase from CNY 1,476,116,816.35 at the end of 2016[21]. - The net assets attributable to shareholders increased to CNY 1,589,084,533.72, a rise of 16.94% from CNY 1,358,917,039.67 in 2016[21]. - The basic earnings per share for 2017 were CNY 0.23, a 15.00% increase from CNY 0.20 in 2016[21]. - The diluted earnings per share also stood at CNY 0.23, reflecting the same 15.00% increase from CNY 0.20 in 2016[21]. - The weighted average return on equity for 2017 was 6.52%, up from 5.94% in 2016[21]. Revenue and Sales Growth - In Q1 2023, the company reported revenue of approximately $400.81 million, which increased to $556.56 million in Q4 2023, showing a quarterly fluctuation[23]. - The company's main business revenue grew by 36.07% year-on-year, with product sales volume increasing by 7.96%[32]. - ACR products accounted for 57.01% of total revenue, while ACM and AMB products contributed 30.18% and 10.24%, respectively[30]. - The revenue from ACR anti-impact modifiers was ¥1,199,058,821.85, with a year-on-year growth of 55.46%[42]. - The revenue from ACM low-temperature toughening agents was ¥634,678,114.26, showing a year-on-year increase of 8.93%[42]. - The sales volume of main business products increased by 7.96% compared to the previous year[41]. Cash Flow and Financial Health - The net cash flow from operating activities was negative in Q4 2023, at approximately -$14.33 million, indicating potential liquidity challenges[23]. - Operating cash inflow increased by 85.61% to ¥2,305,104,613.90, while operating cash outflow decreased by 73.75% to ¥2,255,198,436.90, resulting in a net cash flow of ¥49,906,177.00[62]. - The net cash increase in cash and cash equivalents was ¥70,115,509.13, a 146.28% improvement from the previous year[63]. - The company reported a significant increase in financing cash flow net amounting to ¥146,505,365.24, a 470.47% increase compared to the previous year[63]. Investment and R&D - The company holds 17 invention patents and 17 utility model patents, with 3 new invention patents added during the reporting period[37]. - The company’s R&D investment reached ¥54,765,193.49, representing 2.60% of the operating revenue, a decrease from 2.99% in 2016[62]. - The company is in the promotion and improvement stage for several R&D projects, including anti-static pipe materials and CPVC pipe materials[61]. Dividend Distribution - The company plans to distribute a cash dividend of CNY 1.50 per 10 shares to all shareholders based on the total share capital as of December 31, 2017[9]. - The cash dividend distribution plan for 2017 is CNY 1.50 per 10 shares, totaling CNY 63,871,892.10, which represents 100% of the total profit distribution[116]. - The proposed cash dividend for the 2017 fiscal year is RMB 1.5 per 10 shares, totaling RMB 63.87 million, which is 67.17% of the net profit attributable to shareholders[121]. - The company has consistently paid dividends over the past three years, with a total cash dividend of RMB 124.625 million distributed from 2015 to 2017[121]. Risks and Challenges - The company faces risks related to fluctuations in raw material prices, which could impact profitability and cost control[102]. - The company faces risks of declining product gross margins due to intensified market competition, necessitating continuous innovation in cost optimization and product development[103]. - Safety incidents during the reporting period led to temporary production halts, but operations have since resumed following comprehensive safety evaluations and corrective actions[104]. - The company has been placed on a provincial safety production "blacklist" for 12 months due to safety incidents, which may affect project approvals and funding opportunities[110]. - The macroeconomic environment presents uncertainties that could impact the company's operations in the PVC plastic modifier industry[107]. Corporate Governance and Compliance - The company strictly adheres to corporate governance standards as per the relevant laws and regulations, ensuring compliance with the requirements of the "Code of Corporate Governance for Listed Companies"[199]. - The company conducted its shareholder meetings in accordance with the "Company Law" and related regulations, ensuring equal rights for all shareholders, especially minority shareholders[200]. - The company has ensured compliance with all relevant laws and regulations regarding financial reporting and disclosures[124]. - The company has committed to maintaining transparency and accuracy in its financial reporting to protect the interests of all shareholders[124]. Shareholder Information - The company’s major shareholder, Zhao Dongri, holds 34.58% of the shares, amounting to 147,230,382 shares, with 31,604,442 shares pledged[173]. - The company has a total of 19,741 shareholders as of the report date[173]. - The total number of shares for the 2017 dividend proposal is 425,812,614 shares[119]. - The total remuneration paid to directors, supervisors, and senior management during the reporting period amounted to 2.6788 million yuan[191]. Employee and Workforce - The company employed a total of 836 staff members, with 561 in production, 54 in sales, 121 in technical roles, 29 in finance, and 71 in administration[194]. - The company has one employee with a doctoral degree, 272 with undergraduate or associate degrees, and 563 with vocational or lower education levels[194]. - The company’s training plan focuses on internal training supplemented by external sessions, aimed at enhancing employee skills and overall company performance[196].
日科化学(300214) - 2017 Q3 - 季度财报
2017-10-25 16:00
Financial Performance - Operating revenue for the period reached CNY 616,082,950.91, a 50.94% increase year-on-year[9] - Net profit attributable to shareholders increased by 85.49% to CNY 40,951,085.89 compared to the same period last year[9] - Basic earnings per share reached CNY 0.10, a 100% increase compared to the same period last year[9] - Operating revenue for the current period increased by 40.35% compared to the same period last year, driven by higher product prices and increased sales volume[20] - Operating profit for the current period was ¥100,643,333.44, compared to ¥85,834,750.00 in the previous period, reflecting a growth of approximately 17.3%[49] - Net profit for the current period was ¥77,281,903.52, an increase from ¥66,538,685.79, which is a growth of around 16.5%[49] Assets and Liabilities - Total assets increased by 16.57% to CNY 1,720,716,714.70 compared to the end of the previous year[9] - The total liabilities of the company were CNY 149,435,750.99, compared to CNY 117,199,776.68 at the beginning of the year, showing an increase of about 27.5%[36] - The company's current assets totaled CNY 1,044,442,608.88, up from CNY 857,146,101.88, indicating a growth of about 22%[34] - Accounts receivable increased significantly to CNY 365,345,989.13 from CNY 273,588,070.93, marking a rise of about 33.5%[34] - Inventory levels rose to CNY 138,713,710.75 from CNY 115,463,534.93, which is an increase of approximately 20.1%[34] Cash Flow - The company reported a net cash flow from operating activities of CNY 64,238,015.24, a 100.07% increase year-on-year[9] - Cash flow from operating activities generated a net amount of ¥64,238,015.24, compared to ¥32,108,352.01 in the previous period, indicating a growth of approximately 100.5%[56] - The net cash flow from operating activities was ¥34,670,862.82, compared to a negative cash flow of ¥25,643,049.37 in the previous period, indicating a significant improvement[60] - Total cash inflow from operating activities reached ¥1,062,178,969.94, up from ¥694,263,122.91 in the same period last year, reflecting a growth of approximately 52.9%[59] Shareholder Information - The total number of shareholders at the end of the reporting period was 18,252[13] - The largest shareholder, Zhao Dongri, holds 34.58% of the shares, amounting to 147,230,382 shares[13] - The company reported a commitment to not transfer or entrust the management of shares for 36 months from the date of stock listing[27] - The company’s major shareholders, including Zhao Dongri, committed to not transferring shares exceeding 15% of their total holdings annually during their tenure[27] Financial Commitments and Compliance - The company guarantees the accuracy and completeness of its periodic reports and significant information disclosures[28] - The company has committed to not using insider information for stock trading activities[28] - The company will strictly adhere to relevant laws and regulations regarding stock issuance and management[28] - The company has committed to ensuring that any public communications do not mislead investors regarding stock price[28] Costs and Expenses - Operating costs for the current period increased by 43.96% compared to the same period last year, mainly due to rising raw material prices and increased sales volume[20] - Financial expenses increased by 3.21 times compared to the same period last year, mainly due to reduced deposit interest and increased exchange losses[20] - The company reported a significant increase in sales expenses, which rose to CNY 19,495,948.57 from CNY 17,397,412.69, reflecting an increase of 12%[43] - The company incurred financial expenses of ¥9,136,887.03, compared to a financial income of ¥4,135,462.42 in the previous period, indicating a significant shift in financial performance[49]
日科化学(300214) - 2017 Q2 - 季度财报
2017-08-25 16:00
Financial Performance - Total revenue for the first half of 2017 reached RMB 930,576,175.76, an increase of 34.11% compared to RMB 693,874,330.55 in the same period last year[22]. - Net profit attributable to shareholders decreased by 18.29% to RMB 36,330,817.63 from RMB 44,461,723.64 year-on-year[22]. - Basic earnings per share decreased by 18.18% to RMB 0.09 from RMB 0.11 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was RMB 35,707,591.34, down 16.87% from RMB 42,951,600.78 in the previous year[22]. - The company's gross profit margin for main business products decreased by 4.13 percentage points compared to the same period last year due to intensified market competition[8]. - The company's operating revenue for the reporting period reached ¥930,576,175.76, an increase of 34.11% compared to the same period last year[41]. - The main business income amounted to ¥904,287,258.51, up 33.34% year-on-year, accounting for 97.17% of total revenue[42]. - The company reported a net profit attributable to shareholders of ¥36,330,817.63, down 18.29% year-on-year[41]. - The company reported a significant decline in sales gross margin compared to initial estimates due to fluctuations in raw material prices and market conditions[64]. Cash Flow and Liquidity - Net cash flow from operating activities improved significantly, showing a net inflow of RMB 53,908,191.42 compared to a net outflow of RMB 52,970,995.39 in the previous year, marking a 201.77% increase[22]. - The company reported a 32.13% increase in cash and cash equivalents, totaling CNY 131,132,235.56, attributed to increased cash receipts from sales and bank acceptance bill discounts[50]. - The financial expenses surged by 206.89% to CNY 4,655,622.51, mainly due to increased interest on bank acceptance bill discounts[49]. - The company received CNY 12,274,270.78 from financing activities, a decrease of 91.0% compared to CNY 137,064,658.18 in the previous period[170]. - Cash flow from financing activities resulted in a net outflow of CNY 16,307,767.87, an improvement from a net outflow of CNY 36,722,861.48 in the prior year[171]. Assets and Liabilities - Total assets increased by 2.70% to RMB 1,516,024,205.54 from RMB 1,476,116,816.35 at the end of the previous year[22]. - Accounts receivable rose to CNY 336,454,614.01, a 22.98% increase, due to higher sales revenue[50]. - Inventory increased by 24.16% to CNY 143,358,104.50, driven by rising raw material prices[50]. - Total liabilities rose to CNY 141,026,348.24 from CNY 117,199,776.68, reflecting an increase of about 20.3%[157]. - The company's equity attributable to shareholders increased to CNY 1,374,997,857.30 from CNY 1,358,917,039.67, showing a growth of approximately 1.2%[158]. Investment and Projects - The company has established a sustainable divisional operating model, focusing on customer expectations and integrating marketing efforts[36]. - The construction of a new project for producing 100,000 tons of plastic modifiers and 10,000 tons of chlorinated polyvinyl chloride (CPVC) has progressed, with a 207.52% increase in construction work compared to the beginning of the period[35]. - The company has committed to invest in projects with a total investment of CNY 61,444 million, with a cumulative investment of CNY 71,502.19 million by the end of the reporting period, achieving 116.3% of the planned investment[64]. - The company has adopted a cautious investment strategy to improve the efficiency of raised funds and investment returns[64]. - The company has decided to terminate the "annual production of 70,000 tons of co-extruded color masterbatch (ASA) project" due to changes in market feasibility and demand[64]. Shareholder and Governance - The company has fulfilled commitments related to share transfer restrictions for a period of 36 months since the stock listing, ensuring no transfer of shares during this time[99]. - The controlling shareholder, Zhao Dongri, has committed to not sell more than 25% of his shares annually during his tenure as a director or senior management[99]. - The company has confirmed that there are no violations of regulations regarding financial assistance or compensation related to the non-public offering of shares[100]. - The company has established a commitment to maintain the legitimate rights and interests of all shareholders[100]. - The company has pledged to strictly adhere to the commitments made regarding stock trading behavior during specified periods[100]. Research and Development - The company holds 17 invention patents, continuously strengthening its technological advantages through R&D investment[37]. - Research and development investment was CNY 25,059,920.88, reflecting a slight increase of 1.21% year-on-year[49]. - The company has established a comprehensive product development process to enhance customer satisfaction and address industry shortcomings[46]. Risk Management - The company faces risks from raw material price fluctuations, which could impact profit margins and future profitability[7]. - The company has implemented strategic procurement measures to mitigate risks associated with raw material price volatility[87]. - The company plans to enhance safety management protocols to address risks associated with the use of hazardous chemicals in production[89].
日科化学(300214) - 2017 Q1 - 季度财报
2017-04-24 16:00
Financial Performance - Total revenue for Q1 2017 was CNY 400,810,503.03, representing a 26.55% increase compared to CNY 316,730,905.06 in the same period last year[9]. - Net profit attributable to shareholders decreased by 42.97% to CNY 9,514,022.07 from CNY 16,681,992.62 year-on-year[9]. - Basic earnings per share dropped by 50.00% to CNY 0.02 from CNY 0.04 in the same period last year[9]. - The total profit for Q1 2017 was CNY 13,733,598.10, a decrease of 38.9% compared to CNY 22,377,667.60 in the same period last year[73]. - The net profit for Q1 2017 was CNY 10,300,198.57, down 38.5% from CNY 16,783,250.69 in Q1 2016[73]. - The company reported a total comprehensive income of CNY 10,300,198.57 for Q1 2017, reflecting a decrease of 38.5% from CNY 16,783,250.69 in Q1 2016[73]. Cash Flow - Net cash flow from operating activities increased by 57.15% to CNY 32,065,912.89 compared to CNY 20,404,425.70 in the previous year[9]. - Operating cash flow for Q1 2017 was CNY 32,065,912.89, an increase of 57.3% compared to CNY 20,404,425.70 in Q1 2016[76]. - Cash inflow from operating activities totaled CNY 471,547,388.89, up 59.0% from CNY 296,072,058.75 in the previous year[76]. - Cash outflow from operating activities was CNY 439,481,476.00, an increase of 59.5% compared to CNY 275,667,633.05 in Q1 2016[76]. - The net cash flow from investing activities was -CNY 22,877,475.58, compared to CNY 64,900.96 in the same period last year[76]. - The net cash flow from financing activities was -CNY 4,600,283.99, a decrease from CNY 723,505.73 in Q1 2016[77]. - The ending cash and cash equivalents balance was CNY 171,352,854.26, down from CNY 336,663,728.25 at the end of Q1 2016[77]. - The company received CNY 11,401,927.18 from financing activities, significantly lower than CNY 133,444,845.62 in the previous year[77]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,506,411,155.64, a 2.05% increase from CNY 1,476,116,816.35 at the end of the previous year[9]. - The company's total liabilities amounted to CNY 137,980,093.90, up from CNY 117,199,776.68, which is an increase of about 17.5%[62]. - The company’s equity attributable to shareholders reached CNY 1,368,431,061.74, compared to CNY 1,358,917,039.67, reflecting a slight increase of approximately 0.9%[63]. - The company's inventory increased by 62.77% to CNY 187,938,592.26, primarily due to rising raw material prices[23]. - Accounts receivable decreased by 40.22% to CNY 148,191,437.39, mainly due to cash flow needs[23]. Market and Competition - The company faced risks from raw material price fluctuations, particularly for key materials like methyl methacrylate and styrene, which could impact profitability[11]. - The gross profit margin decreased due to intensified competition, necessitating ongoing cost optimization and innovation to maintain market position[12]. - The gross profit margin declined due to rising raw material costs and intensified market competition, impacting net profit[28]. - The company is facing risks from intensified competition, which may lead to further declines in product gross margins[33]. Strategic Initiatives - The company plans to implement strategic procurement and optimize costs to mitigate risks from raw material price fluctuations[32]. - The company is focusing on marketing and innovation to enhance product sales, with ACR and ACM product sales increasing by 7.37% and 0.14% respectively[28]. - The company is committed to enhancing safety management practices to mitigate risks associated with the handling of hazardous chemicals[13]. - The company has established comprehensive safety management systems to mitigate risks associated with the use of hazardous chemicals in production[34]. Fundraising and Investments - The company has raised up to 160.05 million yuan through a non-public stock issuance to invest in a project with an annual capacity of 100,000 tons of plastic modifier ACM and 10,000 tons of chlorinated polyvinyl chloride CPVC[42]. - The company has received approval from the China Securities Regulatory Commission for its non-public stock issuance application, but is still awaiting the formal approval document[43]. - The company is taking a cautious approach to its fundraising investment projects, adjusting construction plans as necessary to maximize the effectiveness of raised funds[38]. - The total amount of raised funds is 694.49 million CNY, with no funds utilized in the current quarter[48]. - The cumulative amount of raised funds utilized is 715.02 million CNY[48]. - The company has committed to invest a total of 55,444 million CNY, with an adjusted total of 61,444 million CNY for various projects[49]. - The company has adopted a prudent investment strategy to improve the efficiency of raised fund usage and investment returns[50]. Compliance and Governance - The company has made commitments to ensure compliance with relevant regulations and protect shareholder interests[46]. - No financial assistance or compensation provided to investors in relation to the non-public offering of shares[46]. - The company has not engaged in any competing business activities as of the date of the commitment letter[46]. - The company’s major shareholders have committed to avoid any conflicts of interest with the company[46]. - The company’s board members have pledged to fulfill their duties diligently and protect the rights of all shareholders[46]. - There are no violations of commitments made by the company or its major shareholders[46].
日科化学(300214) - 2016 Q4 - 年度财报
2017-04-14 16:00
Financial Performance - The company's operating revenue for 2016 was approximately CNY 1.55 billion, representing an increase of 8.69% compared to 2015[22]. - The net profit attributable to shareholders decreased by 25.40% to approximately CNY 80 million in 2016[22]. - The net cash flow from operating activities was negative CNY 56 million, a decline of 127.13% compared to the previous year[22]. - The basic earnings per share for 2016 was CNY 0.20, down 23.08% from CNY 0.26 in 2015[22]. - The total assets of the company at the end of 2016 were approximately CNY 1.48 billion, a decrease of 4.85% from the previous year[22]. - The company's gross profit margin decreased by 2.56 percentage points compared to 2015 due to intensified market competition[7]. - The net profit after deducting non-recurring gains and losses was approximately CNY 72 million, a decrease of 25.57% from 2015[22]. - The weighted average return on net assets was 5.94%, down from 8.42% in the previous year[22]. Revenue Breakdown - Main business revenue reached CNY 1,506,093,271.51, reflecting a growth of 7.41% year-on-year, with a product sales volume increase of 19.08%[43]. - ACR product sales increased by 19.17%, generating revenue of CNY 771,291,435.05, accounting for 51.21% of main business revenue[43]. - ACM product sales grew by 20.96%, with revenue of CNY 582,630,032.46, representing 38.68% of main business revenue[43]. - AMB product sales rose by 7.60%, achieving revenue of CNY 151,876,932.20, which is 10.08% of main business revenue[43]. - Domestic sales accounted for 74.19% of total revenue, increasing by 11.54% from the previous year[52]. Investment and Projects - The company has committed to invest a total of 24,344 million CNY in various projects, with an actual investment of 31,651.91 million CNY, achieving an investment progress of 105.84% for the ACR project[84]. - The AMB project has an actual investment of 7,479.24 million CNY, representing 98.88% of the committed investment of 7,564 million CNY[84]. - The ACM project has an actual investment of 8,625.48 million CNY, achieving 99.46% of the committed investment of 8,672 million CNY[84]. - The company has decided to terminate the ASA project due to changes in market feasibility, with remaining funds of 85,515.7 million CNY allocated to supplement working capital[86]. Cash Flow and Financial Management - Operating cash inflow decreased by 15.38% to ¥1,241,884,916.40 in 2016 from ¥1,467,587,954.35 in 2015[68]. - The company's cash and cash equivalents decreased by 191.00% to -¥151,488,529.69 in 2016, compared to an increase of ¥166,468,618.88 in 2015[68]. - The company has engaged in cash asset management through entrusted financial management, with amounts reported in ten thousand yuan[169]. - The total amount of entrusted financial management funds is 61,500,000, with 53,500,000 actually recovered[172]. Research and Development - R&D investment amounted to ¥46,239,492.70 in 2016, accounting for 2.99% of operating revenue, down from 3.17% in 2015[67]. - The number of R&D personnel decreased to 139 in 2016, representing 18.17% of total employees, down from 18.67% in 2015[67]. - The company has recognized fixed asset impairment provisions totaling 2,689,624.70 yuan for idle production facilities to reflect the asset status accurately[99]. Shareholder and Dividend Information - The company plans to distribute a cash dividend of CNY 0.50 per 10 shares to shareholders[9]. - The cash dividend for 2016 represents 25.32% of the net profit attributable to ordinary shareholders, which is 79,984,138.19 RMB[136]. - The company has maintained a cash dividend payout ratio of at least 80% during its mature development stage, with the 2016 cash dividend accounting for 100% of the distributable profit[132]. - The total distributable profit at the end of the reporting period is 395,556,313.79 RMB, after accounting for the net profit and legal reserve deductions[133]. Market and Competitive Environment - The company faces risks related to raw material price fluctuations, which could impact profitability and cost control[6]. - The company reported a significant decline in sales gross margin due to changes in macroeconomic conditions and raw material price fluctuations[86]. - The PVC plastic modifier industry is experiencing growth opportunities due to increased demand from downstream PVC processing industries, driven by urbanization and energy-saving initiatives[109]. Corporate Governance and Structure - The company has completed the absorption merger of its wholly-owned subsidiary, optimizing its management structure and reducing operational costs[58]. - The company has two wholly-owned subsidiaries, Shandong Rike Rubber and Plastic Technology Co., Ltd. and Shandong Rike New Materials Co., Ltd.[93]. - The company has not sold any significant assets during the reporting period[90]. - The company has not changed any fundraising projects during the reporting period[89]. Strategic Initiatives - The company plans to expand its business from PVC-related fields to all plastic and rubber sectors, aiming to become a unique problem-solving provider in the plastic industry[111]. - The company is committed to continuous technological innovation to create new products and solutions that meet customer expectations and reduce costs[115]. - The company has implemented a strategic procurement strategy to mitigate risks associated with raw material price volatility[116].
日科化学(300214) - 2016 Q2 - 季度财报(更新)
2016-11-17 09:21
Financial Performance - Total revenue for the first half of 2016 was CNY 693,874,330.55, a decrease of 5.13% compared to CNY 731,382,474.84 in the same period last year[19]. - Net profit attributable to ordinary shareholders was CNY 44,461,723.64, down 10.66% from CNY 49,768,416.24 year-on-year[19]. - Net cash flow from operating activities was negative CNY 52,816,458.95, a significant decline of 1,452.01% compared to CNY 3,906,503.21 in the previous year[19]. - The weighted average return on net assets was 3.33%, down from 3.97% in the previous year[19]. - The company reported a basic earnings per share of CNY 0.11, down 8.33% from CNY 0.12 in the previous year[19]. - The net profit after deducting non-recurring gains and losses was CNY 42,951,600.78, a decrease of 10.09% from CNY 47,773,187.35 in the same period last year[19]. - The company achieved operating revenue of ¥693,874,330.55, a decrease of 5.13% compared to the same period last year[30]. - The net profit attributable to shareholders was ¥44,461,723.64, down 10.66% year-on-year[30]. - The gross profit margin for the main business was 17.41%, a slight decrease of 0.22% compared to the previous year[37]. - The company reported a gross profit margin of approximately 8.1% for the first half of 2016, compared to 8.3% in the same period last year[133]. Cash Flow and Liquidity - The company's cash and cash equivalents decreased by 53.15% to ¥120,356,841.77 due to the repayment of pledged loans[33]. - The net cash flow from operating activities was -52,970,995.39 yuan, a decrease from 3,906,503.21 yuan in the previous period, indicating a significant decline in operational performance[140]. - Total cash inflow from operating activities was 567,486,763.26 yuan, down 11.5% from 641,734,289.72 yuan in the previous period[140]. - Cash outflow from operating activities totaled 620,457,758.65 yuan, slightly lower than 637,827,786.51 yuan in the previous period[140]. - The ending cash and cash equivalents balance was 208,097,013.83 yuan, an increase from 116,612,431.63 yuan in the previous period[140]. Investment and Capital Expenditure - Research and development investment rose to ¥24,759,525.26, an increase of 13.32% year-on-year, accounting for 3.57% of operating revenue[31]. - The total amount of raised funds is CNY 694.49 million, with CNY 19.86 million invested during the reporting period[57]. - CNY 99.28 million was allocated to the annual production of 25,000 tons of plastic modifier (ACR) project[57]. - CNY 75.64 million was invested in the annual production of 15,000 tons of plastic modifier (AMB) project[57]. - CNY 41.72 million was used for the annual production of 10,000 tons of plastic modifier (ACM) project[57]. - The company has taken a cautious approach to investment projects, adjusting construction plans as necessary to maximize the effectiveness of raised funds[55]. Risks and Challenges - The company faces risks from fluctuations in raw material prices, which could impact profit margins and future profitability[24]. - There is a risk of declining product gross margins due to intensified competition in the market[25]. - The company is addressing the risk of increasing accounts receivable by enhancing customer service and linking collection performance to employee evaluations[52]. - The company has identified significant fluctuations in the price of key raw materials, particularly butadiene, affecting the production costs of the AMB product[61]. Shareholder and Equity Information - The total number of shareholders at the end of the reporting period is 22,236[111]. - Zhao Dongri holds 31.21% of the shares, totaling 126,417,768 shares, with 31,604,442 shares pledged[111]. - The total number of restricted shares at the beginning of the period was 107,935,691, with an increase of 2,550,158 shares, resulting in 110,485,849 restricted shares at the end of the period[109]. - The company’s major shareholder, Zhao Dongri, committed to not reducing his shareholding for six months starting from January 8, 2016, to maintain stock stability[101]. Corporate Governance and Management - The company appointed new directors and management on January 6, 2016, as part of a board restructuring[118]. - The company’s commitment to avoid engaging in competing businesses remains valid during the tenure of its directors and for six months post-termination[101]. - The company has not experienced any changes in its controlling shareholder during the reporting period[113]. - The company has not experienced any changes in its actual controller during the reporting period[114]. Financial Position and Assets - Total assets at the end of the reporting period were CNY 1,437,778,260.34, a decrease of 7.32% from CNY 1,551,392,244.31 at the end of the previous year[19]. - Current assets decreased from CNY 970,853,450.18 to CNY 866,979,814.51, a reduction of about 10.7%[124]. - Total liabilities decreased from CNY 231,959,342.83 to CNY 114,383,635.22, a significant reduction of approximately 50.7%[126]. - The company's equity increased slightly from CNY 1,319,432,901.48 to CNY 1,323,394,625.12, an increase of about 0.3%[126]. Future Outlook and Strategy - The company plans to transition from a product-selling model to providing comprehensive solutions for customers, aiming to enhance value creation and profitability[45]. - The company plans to focus on expanding its market presence and investing in new product development in the upcoming quarters[134]. - The company plans to enhance market development efforts for the AMB product to improve downstream integration and sales performance[61]. Compliance and Reporting - The company’s financial statements comply with the requirements of the "Enterprise Accounting Standards" and reflect its financial position as of June 30, 2016[171]. - The company has not reported any changes in accounting policies or prior period error corrections during the current reporting period[154]. - The company’s half-year financial report has not been audited[101].